Innolake Biopharm Company Profile, Contacts & Intelligence

Innolake Biopharm Overview

Innolake Biopharm is a clinical stage biotech company, dedicated to developing innovative medicines against cancer and autoimmune diseases to improve the life of patients around the world. Innolake was co-founded by two industry veterans, Dr. Mingde Xia (former Sr. Director of Global External Innovation at Johnson & Johnson) and Mr. Robert Chen (former founding member and Executive Vice President of Genor Biopharma, one of pioneering therapeutic antibody companies in China) in 2020. The company debuted with a top-tier and enthusiastic scientific & clinical development team and $40 million Series Pre-A. By continuously building proprietary technology platforms and R&D capabilities, Innolake places innovation at the cornerstone of its overall strategy. Through in-house R&D and partnering with MNCs and overseas biotech companies, Innolake has established a robust pipeline with more than ten first-in-class and best-in-class drug candidates, two of which have entered the clinical stage. Recently, Innolake was recognized as a “Chinese Next Unicorn” enterprise and listed on ”2021 China Biopharmaceutical Industry Innovation Top100 List”.

Headquarters

Shanghai, Shanghai Shi, Cn

Website

www.innolakebio.com

Industry

Pharmaceutical Manufacturing

Founded

2020

NAICS

Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing

Innolake Biopharm Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Innolake Biopharm People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Compare Similar Companies to Innolake Biopharm

Explore companies in related markets and compare their industry and employee estimates.